Abstract:The role of the RNA secondary structure in the 5' packaging signal region of human immunodeficiency virus type 1 (HIV-1) in initiating translation of gag mRNA has been investigated both in vitro and in the presence of cellular cofactors in vivo. Heat denaturation of the structure and mutagenic deletion both lead to an increase in levels of translated products, indicating that the structure is a significant inhibitor of translation. The proximity of the gag AUG to the packaging signal structure suggested that it might function as an internal ribosome entry site. However, in both a cell-free system and eukaryotic cells, translation will initiate at a novel upstream initiation codon introduced within the 5' noncoding region. This codon is utilized exclusively, resulting in gag protein products with an extra 11 amino acids at the amino terminus, which, when expressed in T lymphocytes, are confined intracellularly, probably because of the lack of an N-terminal glycine myristoylation signal. Deletion of the secondary structure abolishes gag production even in the presence of tat and rev in trans. Using dicistronic constructs containing the HIV-1 5' leader cloned between two heterologous open reading frames, we were unable to detect any significant expression of the second open reading frame that would have been supportive of an internal ribosome entry site mechanism. Using mutant proviruses either lacking the entire packaging signal structure region or containing the introduced upstream initiation codon in long-term replication studies, we were unable to detect reverse transcriptase activity in culture supernatants. The 5' packaging signal structure of HIV-1 does not serve as an internal ribosome entry site. The translation of gag is consistent with ribosomal scanning. However, the packaging signal structure causes significant translational inhibition.

Dual Role for Motif 1 Residues of Human Lysyl-tRNA Synthetase in Dimerization and Packaging into HIV-1

Packaging HIV virion components through dynamic equilibria of a human tRNA synthetase.

Determinants of the interaction between the 5'-leader of HIV-1 genome and human lysyl-tRNA synthetase in reverse transcription primer release process

Profiling non-lysyl tRNAs in HIV-1.

Association of potent human antiviral cytidine deaminases with 7SL RNA and viral RNP in HIV-1 virions.

MMTV RNA packaging requires an extended long-range interaction for productive Gag binding to packaging signals

The human immunodeficiency virus type 1 5' packaging signal structure affects translation but does not function as an internal ribosome entry site structure

Role of RNA structural plasticity in modulating HIV-1 genome packaging and translation

Structure of the HIV-1 RNA packaging signal

The three-way junction structure of the HIV-1 PBS-segment binds host enzyme important for viral infectivity

Roles of RNA scaffolding in nanoscale Gag multimerization and selective protein sorting at HIV membranes

Virion Packaging Determinants And Reverse Transcription Of Srp Rna In Hiv-1 Particles

Selective packaging of HIV-1 RNA genome is guided by the stability of 5' untranslated region polyA stem

Interplay between protease and reverse transcriptase dimerization in a model HIV‐1 polyprotein

RNA-Binding Domains of Heterologous Viral Proteins Substituted for Basic Residues in the RSV Gag NC Domain Restore Specific Packaging of Genomic RNA

HIV-1 Matrix-Trna Complex Structure Reveals Basis for Host Control of Gag Localization.

Conserved Residue Lys574 in the Cavity of HIV-1 Gp41 Coiled-coil Domain is Critical for Six-helix Bundle Stability and Virus Entry*

HIV-1 RNA genome packaging: it's G-rated

Co-crystal structures of HIV TAR RNA bound to lab-evolved proteins show key roles for arginine relevant to the design of cyclic peptide TAR inhibitors

Analysis of the human immunodeficiency virus-1 RNA packageome

Mapping HIV-1 RNA Structure, Homodimers, Long-Range Interactions and persistent domains by HiCapR